Exact Sciences (EXAS) Operating Leases (2019 - 2025)

Exact Sciences (EXAS) has 7 years of Operating Leases data on file, last reported at $161.9 million in Q4 2025.

• Operating Leases for Q4 2025 came in at $161.9 million, up 3.03% year-over-year; the trailing twelve-month figure through Dec 2025 was $161.9 million (up 3.03% YoY), and the FY2025 annual result was $161.9 million, up 3.03% from the prior year.
• Operating Leases retreated to $161.9 million in Q4 2025 per EXAS's latest filing, from $163.9 million in the prior quarter.
• Over five years, Operating Leases peaked at $210.8 million in Q4 2022 and troughed at $157.1 million in Q4 2024.
• A 5-year average of $180.8 million and a median of $182.8 million in 2021 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2021 and 2024: Operating Leases jumped 66.76% in 2021, then dropped 20.66% in 2024.
• A 5-year view of Operating Leases shows it stood at $201.9 million in 2021, then climbed by 4.41% to $210.8 million in 2022, then fell by 9.68% to $190.4 million in 2023, then slipped by 17.47% to $157.1 million in 2024, then rose by 3.03% to $161.9 million in 2025.
• Business Quant data shows EXAS's Operating Leases at $161.9 million in Q4 2025, $163.9 million in Q3 2025, and $166.0 million in Q2 2025.